文献速递神经创伤神经重症

创伤性脑损伤后用于降低颅内压的药物治疗药物比较

A Comparison of Pharmacologic Therapeutic Agents Used for the Reduction of Intracranial Pressure After Traumatic Brain Injury.
PubMed 文献 · World Neurosurg · 2017-07-14

本综述通过PubMed检索比较创伤性脑损伤(TBI)后降低颅内压的药物治疗效果。高渗盐水与颅内高压缓解更快及脑血流动力学恢复相关,但未转化为长期 morbidity 或 mortality 获益;对高渗治疗无效者可诱导巴比妥昏迷降低颅内压,但需密切监测。作者认为高渗盐水是即刻降低颅内压的最佳选择。

要点

  • 高渗盐水与颅内高压更快缓解和脑血流动力学恢复相关,但未转化为长期 morbidity 或 mortality 获益。
  • 对高渗治疗无效的患者,诱导巴比妥昏迷可降低颅内压,但需密切监测以预防不良事件。
  • 作者认为TBI后使用高渗盐水是即刻降低颅内压的最佳选择。

核心结论

  • 当前研究表明,TBI后使用高渗盐水是即刻降低颅内压的最佳选择。
  • 更好地理解每种治疗方案的疗效有助于指导创伤救治关键早期数小时的治疗流程,并持续改善TBI后的 morbidity 和 mortality。

研究设计与样本

  • 本综述通过PubMed检索进行,仅纳入讨论TBI后患者药物治疗的研究。
  • 纳入前瞻性和回顾性研究,包括随机对照试验以及队列、病例对照、观察性和数据库研究。
  • 排除系统文献综述、Meta分析以及考虑非TBI情况或儿科人群的研究。

主要发现

  • 文献中最常讨论的药物包括高渗盐水、甘露醇等高渗药物,芬太尼、丙泊酚等镇静药,苯二氮䓬类和巴比妥类。
  • 高渗盐水与颅内高压更快缓解和最佳脑血流动力学恢复相关,但这些优势未转化为长期 morbidity 或 mortality 获益。
  • 对高渗治疗无效的患者,诱导巴比妥昏迷可降低颅内压,但需要密切监测以预防不良事件。

临床怎么用

  • 作者认为TBI后使用高渗盐水是即刻降低颅内压的最佳选择。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: In neurotrauma care, a better understanding of treatments after traumatic brain injury (TBI) has led to a significant decrease in morbidity and mortality in this population. TBI represents a significant medical problem, and complications after TBI are associated with the initial injury and postevent intracranial processes such as increased intracranial pressure and brain edema. Consequently, appropriate therapeutic interventions are required to reduce brain tissue damage and improve cerebral perfusion. We present a contemporary review of literature on the use of pharmacologic therapies to reduce intracranial pressure after TBI and a comparison of their efficacy. METHODS: This review was conducted by PubMed query. Only studies discussing pharmacologic management of patients after TBI were included. This review includes prospective and retrospective studies and includes randomized controlled trials as well as cohort, case-control, observational, and database studies. Systematic literature reviews, meta-analyses, and studies that considered conditions other than TBI or pediatric populations were not included. RESULTS: Review of the literature describing the current pharmacologic treatment for intracranial hypertension after TBI most often discussed the use of hyperosmolar agents such as hypertonic saline and mannitol, sedatives such as fentanyl and propofol, benzodiazepines, and barbiturates. Hypertonic saline is associated with faster resolution of intracranial hypertension and restoration of optimal cerebral hemodynamics, although these advantages did not translate into long-term benefits in morbidity or mortality. In patients refractory to treatment with hyperosmolar therapy, induction of a barbiturate coma can reduce intracranial pressure, although requires close monitoring to prevent adverse events. CONCLUSIONS: Current research suggests that the use of hypertonic saline after TBI is the best option for immediate decrease in intracranial pressure. A better understanding of the efficacy of each treatment option can help to direct treatment algorithms during the critical early hours of trauma care and continue to improve morbidity and mortality after TBI.

来源:World Neurosurg,查看原文。版权归原作者所有。

引用

  1. Alnemari AM, Krafcik BM, Mansour TR, et al. A Comparison of Pharmacologic Therapeutic Agents Used for the Reduction of Intracranial Pressure After Traumatic Brain Injury. World Neurosurg. 2017. PMID: 28712906. doi:10.1016/j.wneu.2017.07.009

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。